Retension Pharmaceuticals
RTSN
#9759
Rank
โ‚น9.48 B
Marketcap
โ‚น1,138
Share price
1.08%
Change (1 day)
N/A
Change (1 year)

Retension Pharmaceuticals (RTSN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น2.90 Billion

According to Retension Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น2.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Retension Pharmaceuticals - Total liabilities on balance sheet (from 2025 to 2026)